Precision Medicine
Precision medicine tailors treatments to the needs of individual patients by considering genetic, environmental and lifestyle factors. They can target the underlying causes of a patient’s condition, improve effectiveness, and reduce side effects.
OHE Involved in Developing New AMS Report on Stratified Medicines
15 July 2013
Professor Adrian Towse, OHE’s Director, joined Professor Sir John Bell and Professor Andrew Morris at the Science Media Centre last week to launch Realising the Potential…
Forecasting the Challenges and Economics of Drug Development in 2022
9 July 2013
A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for…
OHE’s Towse on Challenges in Valuing Genomic Medicines
23 May 2013
In this video, Adrian Towse discusses the challenges and importance of appropriately valuing genomic medicine. He addresses both gene therapies and “pharmacogenomics” — those medicines that…
Valuing Co-Dependent Medical Technologies: Improving Methods and Processes
23 April 2013
Advances in science and technology are producing more and better means for diagnosing disease, matching patients to the best therapies, and tracking the progress of treatment.…
Join OHE in a Seminar to Discuss IP, Innovation and the Human Genome
19 October 2012
In this OHE lunchtime seminar, Prof Heidi Williams of MIT will present the results of a recent paper using newly-collected data on the sequencing of the…
Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference
11 October 2012
To celebrate its 50th Anniversary, OHE held a conference this week, The Challenges and Economics of Drug Development in 2022, which explored the likely evolution of…